FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Guggenheim Increases Price Target for Johnson & Johnson

      Guggenheim Partners has raised its price target for Johnson & Johnson (NYSE: JNJ) from $244 to $266, maintaining a Buy rating on the stock. This adjustment follows the company's first-quarter earnings report, which prompted the firm to update its financial model for the healthcare giant.

      Johnson & Johnson has been recognized as one of the top ten Dow stocks to invest in currently. The increase in the price target reflects Guggenheim's positive outlook on the company's performance and potential for growth.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud